# NLI Holdings, Inc.: financial statements, quarterly

NL · NYSE · CIK 72162 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nl.md) · [Financials](/companies/nl/financials.md) · [Filings](/companies/nl/filings.md) · [Insiders](/companies/nl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [40.4](/filings/0001558370-24-014643.md) | [43.2 d](/filings/0001104659-26-025290.md) | [38.0](/filings/0001558370-25-006752.md) | [35.9](/filings/0001558370-25-010532.md) | [33.7](/filings/0001104659-25-107766.md) | [38.4 d](/filings/0001104659-26-025290.md) | [40.3](/filings/0001104659-26-056285.md) | [40.4](/filings/0001104659-26-091146.md) | [40.0](/filings/0001104659-25-107766.md) | [37.7 d](/filings/0001104659-26-025290.md) | [40.6](/filings/0001104659-26-056285.md) | [43.6](/filings/0001104659-26-091146.md) |
| Cost of revenue | $m | [27.7](/filings/0001558370-24-014643.md) | [29.5 d](/filings/0001104659-26-025290.md) | [28.3](/filings/0001558370-25-006752.md) | [24.7](/filings/0001558370-25-010532.md) | [24.2](/filings/0001104659-25-107766.md) | [27.4 d](/filings/0001104659-26-025290.md) | [28.1](/filings/0001104659-26-056285.md) | [27.5](/filings/0001104659-26-091146.md) | [28.9](/filings/0001104659-25-107766.md) | [25.6 d](/filings/0001104659-26-025290.md) | [27.3](/filings/0001104659-26-056285.md) | [28.1](/filings/0001104659-26-091146.md) |
| Gross profit | $m | [12.6](/filings/0001558370-24-014643.md) | [13.6 d](/filings/0001104659-26-025290.md) | [9.7](/filings/0001558370-25-006752.md) | [11.2](/filings/0001558370-25-010532.md) | [9.5](/filings/0001104659-25-107766.md) | [11.1 d](/filings/0001104659-26-025290.md) | [12.2](/filings/0001104659-26-056285.md) | [12.9](/filings/0001104659-26-091146.md) | [11.0](/filings/0001104659-25-107766.md) | [12.1 d](/filings/0001104659-26-025290.md) | [13.3](/filings/0001104659-26-056285.md) | [15.5](/filings/0001104659-26-091146.md) |
| Selling, general and administrative | $m | [6.1](/filings/0001558370-24-014643.md) | [6.1 d](/filings/0001104659-26-025290.md) | [6.0](/filings/0001558370-25-006752.md) | [6.1](/filings/0001558370-25-010532.md) | [6.1](/filings/0001104659-25-107766.md) | [6.2 d](/filings/0001104659-26-025290.md) | [6.3](/filings/0001104659-26-056285.md) | [6.6](/filings/0001104659-26-091146.md) | [6.3](/filings/0001104659-25-107766.md) | [6.4 d](/filings/0001104659-26-025290.md) | [6.2](/filings/0001104659-26-056285.md) | [6.6](/filings/0001104659-26-091146.md) |
| Operating income | $m | [3.7](/filings/0001558370-24-014643.md) | [4.8 d](/filings/0001104659-26-025290.md) | [1.4](/filings/0001558370-25-006752.md) | [0.8](/filings/0001558370-25-010532.md) | [2.0](/filings/0001104659-25-107766.md) | [33.7 d](/filings/0001104659-26-025290.md) | [3.1](/filings/0001104659-26-056285.md) | [2.8](/filings/0001104659-26-091146.md) | [1.9](/filings/0001104659-25-107766.md) | [2.9 d](/filings/0001104659-26-025290.md) | [4.1](/filings/0001104659-26-056285.md) | [6.1](/filings/0001104659-26-091146.md) |
| Interest expense | $m | [0.2](/filings/0001558370-23-017430.md) | [0.1 d](/filings/0001558370-24-002620.md) | [0.1](/filings/0001558370-24-007351.md) | [0.1](/filings/0001558370-24-011367.md) | [0.1](/filings/0001104659-25-107766.md) | [0.1 d](/filings/0001104659-26-025290.md) | [0.6](/filings/0001104659-26-056285.md) | [0.1](/filings/0001104659-26-091146.md) | [0.1](/filings/0001104659-25-107766.md) | [0.0 d](/filings/0001104659-26-025290.md) | [0.0](/filings/0001104659-26-056285.md) | [0.0](/filings/0001104659-26-091146.md) |
| Income tax | $m | [(1.0)](/filings/0001558370-24-014643.md) | [(0.2) d](/filings/0001104659-26-025290.md) | [1.0](/filings/0001558370-25-006752.md) | [1.3](/filings/0001558370-25-010532.md) | [8.5](/filings/0001104659-25-107766.md) | [3.3 d](/filings/0001104659-26-025290.md) | [(0.0)](/filings/0001104659-26-056285.md) | [(0.0)](/filings/0001104659-26-091146.md) | [(0.9)](/filings/0001104659-25-107766.md) | [(15.1) d](/filings/0001104659-26-025290.md) | [1.5](/filings/0001104659-26-056285.md) | [2.5](/filings/0001104659-26-091146.md) |
| Net income | $m | [(0.1)](/filings/0001558370-24-014643.md) | [7.6 d](/filings/0001104659-26-025290.md) | [6.8](/filings/0001558370-25-006752.md) | [7.8](/filings/0001558370-25-010532.md) | [36.0](/filings/0001104659-25-107766.md) | [16.5 d](/filings/0001104659-26-025290.md) | [0.7](/filings/0001104659-26-056285.md) | [0.4](/filings/0001104659-26-091146.md) | [(7.9)](/filings/0001104659-25-107766.md) | [(31.0) d](/filings/0001104659-26-025290.md) | [4.3](/filings/0001104659-26-056285.md) | [9.0](/filings/0001104659-26-091146.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001558370-23-017430.md) | not reported | [0.14](/filings/0001558370-25-006752.md) | [0.16](/filings/0001558370-25-010532.md) | [0.74](/filings/0001104659-25-107766.md) | not reported | [0.01](/filings/0001104659-26-056285.md) | [0.01](/filings/0001558370-25-010532.md) | [(0.16)](/filings/0001104659-25-107766.md) | not reported | [0.09](/filings/0001104659-26-056285.md) | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001558370-24-014643.md) | not reported | [0.14](/filings/0001558370-25-006752.md) | [0.16](/filings/0001558370-25-010532.md) | [0.74](/filings/0001104659-25-107766.md) | not reported | [0.01](/filings/0001104659-26-056285.md) | [0.01](/filings/0001104659-26-091146.md) | [(0.16)](/filings/0001104659-25-107766.md) | not reported | [0.09](/filings/0001104659-26-056285.md) | [0.18](/filings/0001104659-26-091146.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [65.8](/filings/0001558370-23-017430.md) | [112](/filings/0001558370-25-002417.md) | [138](/filings/0001558370-24-007351.md) | [167](/filings/0001558370-24-011367.md) | [146](/filings/0001558370-24-014643.md) | [163](/filings/0001104659-26-025290.md) | [110](/filings/0001558370-25-006752.md) | [111](/filings/0001558370-25-010532.md) | [102](/filings/0001104659-25-107766.md) | [111](/filings/0001104659-26-091146.md) | [102](/filings/0001104659-26-056285.md) | [107](/filings/0001104659-26-091146.md) |
| Current assets | $m | [206](/filings/0001558370-23-017430.md) | [218](/filings/0001558370-25-002417.md) | [218](/filings/0001558370-24-007351.md) | [227](/filings/0001558370-24-011367.md) | [226](/filings/0001558370-24-014643.md) | [238](/filings/0001104659-26-025290.md) | [180](/filings/0001558370-25-006752.md) | [184](/filings/0001558370-25-010532.md) | [174](/filings/0001104659-25-107766.md) | [160](/filings/0001104659-26-091146.md) | [156](/filings/0001104659-26-056285.md) | [164](/filings/0001104659-26-091146.md) |
| Total assets | $m | [570](/filings/0001558370-23-017430.md) | [577](/filings/0001558370-25-002417.md) | [569](/filings/0001558370-24-007351.md) | [580](/filings/0001558370-24-011367.md) | [586](/filings/0001558370-24-014643.md) | [578](/filings/0001104659-26-025290.md) | [520](/filings/0001558370-25-006752.md) | [524](/filings/0001558370-25-010532.md) | [500](/filings/0001104659-25-107766.md) | [464](/filings/0001104659-26-091146.md) | [461](/filings/0001104659-26-056285.md) | [471](/filings/0001104659-26-091146.md) |
| Current liabilities | $m | [30.0](/filings/0001558370-23-017430.md) | [30.4](/filings/0001558370-25-002417.md) | [24.6](/filings/0001558370-24-007351.md) | [29.6](/filings/0001558370-24-011367.md) | [33.6](/filings/0001558370-24-014643.md) | [91.1](/filings/0001104659-26-025290.md) | [30.9](/filings/0001558370-25-006752.md) | [34.0](/filings/0001558370-25-010532.md) | [35.2](/filings/0001104659-25-107766.md) | [20.6](/filings/0001104659-26-091146.md) | [14.6](/filings/0001104659-26-056285.md) | [18.1](/filings/0001104659-26-091146.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [364](/filings/0001558370-23-017430.md) | [370](/filings/0001558370-25-002417.md) | [368](/filings/0001558370-24-007351.md) | [373](/filings/0001558370-24-011367.md) | [386](/filings/0001558370-24-014643.md) | [397](/filings/0001104659-26-025290.md) | [398](/filings/0001558370-25-006752.md) | [398](/filings/0001558370-25-010532.md) | [375](/filings/0001104659-25-107766.md) | [359](/filings/0001104659-26-091146.md) | [359](/filings/0001104659-26-056285.md) | [363](/filings/0001104659-26-091146.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.5) d](/filings/0001558370-24-014643.md) | [21.5 d](/filings/0001104659-26-025290.md) | [6.7](/filings/0001558370-25-006752.md) | [15.5 d](/filings/0001558370-25-010532.md) | [(5.7) d](/filings/0001104659-25-107766.md) | [9.0 d](/filings/0001104659-26-025290.md) | [(47.5)](/filings/0001104659-26-056285.md) | [7.3 d](/filings/0001104659-26-091146.md) | [7.9 d](/filings/0001104659-25-107766.md) | [(4.2) d](/filings/0001104659-26-025290.md) | [(3.5)](/filings/0001104659-26-056285.md) | [11.0 d](/filings/0001104659-26-091146.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001558370-24-014643.md) | [0.6 d](/filings/0001104659-26-025290.md) | [0.3](/filings/0001558370-25-006752.md) | [0.4 d](/filings/0001558370-25-010532.md) | [0.5 d](/filings/0001104659-25-107766.md) | [0.2 d](/filings/0001104659-26-025290.md) | [0.8](/filings/0001104659-26-056285.md) | [1.3 d](/filings/0001104659-26-091146.md) | [1.0 d](/filings/0001104659-25-107766.md) | [0.6 d](/filings/0001104659-26-025290.md) | [0.4](/filings/0001104659-26-056285.md) | [1.1 d](/filings/0001104659-26-091146.md) |
| Dividends paid | $m | [3.4 d](/filings/0001558370-24-014643.md) | [3.4 d](/filings/0001104659-26-025290.md) | [3.9](/filings/0001558370-25-006752.md) | [3.9 d](/filings/0001558370-25-010532.md) | [24.9 d](/filings/0001104659-25-107766.md) | [3.9 d](/filings/0001104659-26-025290.md) | [4.4](/filings/0001104659-26-056285.md) | [4.4 d](/filings/0001104659-26-091146.md) | [14.7 d](/filings/0001104659-25-107766.md) | [4.4 d](/filings/0001104659-26-025290.md) | [4.9](/filings/0001104659-26-056285.md) | [4.9 d](/filings/0001104659-26-091146.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.8](/filings/0001558370-23-012927.md) | [48.8](/filings/0001558370-23-017430.md) | [48.8](/filings/0001558370-24-007351.md) | [48.8](/filings/0001558370-24-011367.md) | [48.8](/filings/0001558370-24-014643.md) | [48.8](/filings/0001558370-25-006752.md) | [48.8](/filings/0001558370-25-010532.md) | [48.8](/filings/0001104659-25-107766.md) | [48.8](/filings/0001104659-26-056285.md) | [48.9](/filings/0001558370-25-010532.md) | [48.9](/filings/0001104659-25-107766.md) | [48.9](/filings/0001104659-26-056285.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,898,734 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091146.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.